JPWO2021255900A1 - - Google Patents

Info

Publication number
JPWO2021255900A1
JPWO2021255900A1 JP2021523527A JP2021523527A JPWO2021255900A1 JP WO2021255900 A1 JPWO2021255900 A1 JP WO2021255900A1 JP 2021523527 A JP2021523527 A JP 2021523527A JP 2021523527 A JP2021523527 A JP 2021523527A JP WO2021255900 A1 JPWO2021255900 A1 JP WO2021255900A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021523527A
Other versions
JP6933834B1 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2021130913A priority Critical patent/JP2022000635A/ja
Application granted granted Critical
Publication of JP6933834B1 publication Critical patent/JP6933834B1/ja
Publication of JPWO2021255900A1 publication Critical patent/JPWO2021255900A1/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021523527A 2020-06-18 2020-06-18 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー Active JP6933834B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021130913A JP2022000635A (ja) 2020-06-18 2021-08-10 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2020/023982 WO2021255900A1 (ja) 2020-06-18 2020-06-18 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021130913A Division JP2022000635A (ja) 2020-06-18 2021-08-10 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー

Publications (2)

Publication Number Publication Date
JP6933834B1 JP6933834B1 (ja) 2021-09-08
JPWO2021255900A1 true JPWO2021255900A1 (ja) 2021-12-23

Family

ID=77549998

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021523527A Active JP6933834B1 (ja) 2020-06-18 2020-06-18 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー
JP2021130913A Pending JP2022000635A (ja) 2020-06-18 2021-08-10 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021130913A Pending JP2022000635A (ja) 2020-06-18 2021-08-10 新型コロナウイルス感染者の重症化リスクの検査方法、その検査キット、コンパニオン診断薬及びその重症化リスクマーカー

Country Status (3)

Country Link
US (1) US20230221337A1 (ja)
JP (2) JP6933834B1 (ja)
WO (1) WO2021255900A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022030629A1 (ja) * 2020-08-07 2022-02-10 和幸 吉崎 ウイルス感染症状、治療法適合性、および／または治療結果を予測するための方法
JPWO2023007809A1 (ja) * 2021-07-29 2023-02-02
WO2023063021A1 (ja) * 2021-10-11 2023-04-20 国立大学法人大阪大学 患者の分類方法、キットおよびバイオマーカーの使用
WO2024029523A1 (ja) * 2022-08-02 2024-02-08 応用酵素医学研究所株式会社 コロナウイルス感染症の評価項目を判断するための情報を提供する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973470B2 (en) * 2015-07-19 2021-04-13 Sanmina Corporation System and method for screening and prediction of severity of infection
JP6581273B1 (ja) * 2018-09-28 2019-09-25 シミックホールディングス株式会社 肝型脂肪酸結合タンパク質を定量する方法、その定量用キット、腎疾患の検査方法、その検査キット及びコンパニオン診断薬
US10689716B1 (en) * 2020-03-19 2020-06-23 University Of Miami Materials and methods for detecting coronavirus

Also Published As

Publication number Publication date
WO2021255900A1 (ja) 2021-12-23
US20230221337A1 (en) 2023-07-13
JP2022000635A (ja) 2022-01-04
JP6933834B1 (ja) 2021-09-08

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR102021015500A2 (ja)
BR112022009896A2 (ja)
BR112023011738A2 (ja)
JPWO2023007809A1 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR112023011539A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)
BR102021015566A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210422

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210630

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210713

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210810

R150 Certificate of patent or registration of utility model

Ref document number: 6933834

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150